Skip to main content

Theratechnologies(TH-T)
TSX

Today's Change
Real-Time Last Update

Stocks in play: Theratechnologies Inc.

Baystreet - Thu Mar 28, 10:10AM CDT

Today announced two posters will be presented at the American Association for Cancer Research (AACR) Annual Meeting 2024, demonstrating the potential of its SORT1+ Technology™ platform – including novel camptothecin-peptide conjugates and its lead investigational peptide drug conjugate (PDC) candidate, sudocetaxel zendusortide (TH1902), as anticancer treatments. The AACR meeting is taking place April 5-10 in San Diego, CA. Theratechnologies Inc. shares T.TH are trading up $0.05 at $2.03.

Provided Content: Content provided by Baystreet. The Globe and Mail was not involved, and material was not reviewed prior to publication.

More from The Globe